A conversation with Aled Edwards

As the Structural Genomics Consortium enters its second decade, the challenge has shifted from showing that its model of providing open access to biological data is sustainable to expanding intellectual and geographic reach. Thus, the consortium now is looking to engage clinical scientists and add a site in South America.

The SGC is a not-for-profit public-private partnership (PPP) that produces 3D structures of biomedically relevant proteins as well as chemical tools that enable drug discovery. Outputs from the consortium are placed in the public domain without IP restrictions...